Subsequent Events (Details) - USD ($) $ in Millions |
3 Months Ended | |||
---|---|---|---|---|
Aug. 04, 2025 |
Sep. 30, 2025 |
Jun. 30, 2025 |
Jun. 30, 2024 |
|
Pillar5 Pharma | Forecast | ||||
Subsequent Event [Line Items] | ||||
Purchase price | $ 100.0 | |||
Restricted Stock Units (RSUs) | ||||
Subsequent Event [Line Items] | ||||
Granted (in shares) | 114,900 | 131,900 | ||
Subsequent Event | Director | ||||
Subsequent Event [Line Items] | ||||
Number of shares of common stock delivered for each vested restricted stock unit (in shares) | 1 | |||
Subsequent Event | Director | Restricted Stock Units (RSUs) | ||||
Subsequent Event [Line Items] | ||||
Granted (in shares) | 2,094 | |||
Award vesting period (years) | 1 year |
X | ||||||||||
- Definition Common Stock, Number of Shares Delivered for Each Vested Restricted Stock Unit No definition available.
|
X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|